Stock listing
NASDAQ:NGM NGM Biopharmaceuticals Inc Stock
Follow NGM Biopharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:NGM
$1.54 USD
Close on Apr 8, 2024 · No longer trades
- Lowest – highest close
- $0.60 – $31.93 USDSince Apr 4, 2019 · lowest Nov 17, 2023 · highest Mar 17, 2021
Delisted NASDAQ:NGM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:NGM
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
NGM Biopharmaceuticals Inc on 6ix
- Decks
- 1 deck · latest Jan 13, 2020
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (January 2020) | Investor deck | 36 slides | Jan 13, 2020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mark Leschly Other companies: ChargePoint Holdings, Inc. (Managing Partner, Rho Capital Partners, Rho Ventures · Since at least Feb 26, 2021); NephroGenex Inc (Director · Feb 10, 2014 – Feb 14, 2014 · Past); Bluefly Inc (Director · Feb 25, 2010 – May 23, 2013 · Past); Verenium Corp (Director · Jul 20, 2006 – Feb 13, 2009 · Past); Nitromed Inc (Director · May 9, 2006 – Apr 24, 2009 · Past); Senomyx Inc (Director · Jan 26, 2006 – May 31, 2007 · Past) | Director · Apr 3, 2019 – Jun 8, 2021 · Past |
| Carole Ho Other companies: Eli Lilly and Company (Executive Vice President and President, Lilly Neuroscience · Since at least Dec 31, 2025); Royalty Pharma plc (Director · Since at least Jul 17, 2025); Beam Therapeutics Inc. (Director · Since at least Feb 5, 2020); Denali Therapeutics Inc. (Chief Medical Officer · Since at least Apr 1, 2019) | Director · Jun 5, 2020 – Apr 5, 2024 · Past |
| Peter Svennilson Other companies: RAPT Therapeutics Inc (Director · Jun 18, 2020 – May 28, 2021 · Past); Revolution Medicines, Inc. (Director · Jun 17, 2020 – Apr 26, 2021 · Past); ORIC Pharmaceuticals, Inc. (Director · Apr 23, 2020 – Jun 16, 2021 · Past); Gritstone bio, Inc. (Director · Jun 19, 2019 – Jun 19, 2019 · Past) | Director · Apr 3, 2019 – Apr 8, 2020 · Past |
| David V Goeddel Other companies: Tenaya Therapeutics, Inc. (Director · Since at least Jul 29, 2021); Nurix Therapeutics, Inc. (Director · Jul 28, 2020 – Jul 28, 2020 · Past); RAPT Therapeutics Inc (Director · Oct 30, 2019 – Nov 4, 2019 · Past) | Director · Apr 3, 2019 – Apr 5, 2024 · Past |
| Jean-Frédéric Viret Other companies: SpyGlass Pharma, Inc. (Chief Financial Officer · Since at least Feb 5, 2026); Coherus Oncology, Inc. (Chief Financial Officer · Nov 6, 2014 – Feb 1, 2021 · Past); Anesiva Inc (VP and Chief Financial Officer · Mar 1, 2008 – Dec 3, 2008 · Past) | Chief Financial Officer · Nov 3, 2023 – Mar 26, 2024 · Past |
| William Rieflin Other companies: Lyell Immunopharma, Inc. (Director · Since at least Jun 16, 2021); RAPT Therapeutics Inc (Director · Oct 30, 2019 – May 22, 2024 · Past); XenoPort Inc (Director · May 17, 2016 – Jul 5, 2016 · Past) | Director · Apr 3, 2019 – Apr 5, 2024 · Past |
| Mangini Siobhan Nolan Other companies: Alight, Inc. (Director · Since at least Jan 1, 2024); Castlight Health Inc (President · Jul 8, 2016 – Feb 16, 2020 · Past) | President and CFO · Jul 13, 2020 – Mar 2, 2023 · Past |
| Suzanne Sawochka Hooper Other companies: Eidos Therapeutics Inc (Director · Aug 6, 2020 – Jan 26, 2021 · Past); Jazz Pharmaceuticals plc (EVP & General Counsel · Mar 12, 2012 – Feb 25, 2019 · Past) | Director · Apr 3, 2019 – Apr 5, 2024 · Past |
| David J. Woodhouse Other companies: Surrozen, Inc. (Chairman of the Board · Since at least Aug 11, 2021) | Chief Executive Officer, Director · Apr 3, 2019 – Apr 5, 2024 · Past |
| David Schnell Other companies: Kythera Biopharmaceuticals Inc (Director · Oct 10, 2012 – Jun 5, 2014 · Past) | Director · Apr 3, 2019 – May 20, 2020 · Past |
All 18 people
| Person | Seat |
|---|---|
| Jin-Long Chen Other companies: Tenaya Therapeutics, Inc. (Director · Jul 29, 2021 – Jun 9, 2023 · Past) | Chief Scientific Officer, Director · Apr 3, 2019 – Mar 2, 2023 · Past |
| McHenry T Tichenor Other companies: Belo Corp (Director · Aug 3, 2009 – Dec 31, 2013 · Past) | Director · Apr 3, 2019 – May 20, 2020 · Past |
| Roger Perlmutter Other companies: Eikon Therapeutics, Inc. (See remarks, Director · Since at least Feb 4, 2026) | Director · May 18, 2022 – Apr 5, 2024 · Past |
| Shelly D Guyer Other companies: Veracyte, Inc. (Chief Financial Officer · Oct 29, 2013 – Mar 1, 2016 · Past) | Director · Dec 3, 2019 – Apr 5, 2024 · Past |
| Valerie L Pierce Other companies: Sunesis Pharmaceuticals Inc (SVP & General Counsel · Apr 16, 2007 – Jun 30, 2008 · Past) | See Remarks · Mar 3, 2021 – Mar 26, 2024 · Past |
| Aetna Wun Trombley | President & COO · Apr 3, 2019 – Feb 4, 2020 · Past |
| Hsiao D Lieu | Chief Medical Officer · Mar 11, 2020 – Apr 5, 2024 · Past |
| Irene Perlich | Principal Accounting Officer · Sep 15, 2023 – Apr 5, 2024 · Past |
Log in to ask 6ix AI your own questions about NGM Biopharmaceuticals Inc.